Dr. Benjamin Waldmann

Dr. Benjamin Waldmann has extensive work experience in the medical industry. Dr. Benjamin is currently the CEO of Xenios AG, a Fresenius Medical Care company. Prior to this role, they held various positions at Fresenius Medical Care, including Senior Vice President of Heart, Lung, and Therapeutic Apheresis. Dr. Benjamin also served as Vice President of HD Devices and Vice President of Machines Germany. Before joining Fresenius, Dr. Waldmann worked at Siemens Healthineers as the Head of Medical Electronic R&D Customer Management and Team Manager for RF and Mixed-Signal Processing. Dr. Benjamin also worked at Siemens as a Program Manager and Development Engineer. Dr. Benjamin started their career as a Research Assistant at the Friedrich-Alexander-University of Erlangen-Nürnberg.

Dr. Benjamin Waldmann received their education in Elektrotechnik, Elektronik und Informationstechnik. Dr. Benjamin obtained a Diplom Ingenieur degree from FAU Erlangen-Nürnberg in 2006. Subsequently, they earned a Dr.-Ing. degree from the same institution in 2010.